CCX354 is an antagonist of CCR1, with anti-inflammatory activity.
性状
Solid
IC50 & Target[1][2]
CCR1
体外研究(In Vitro)
CCX354 shows potent activities in the chemotaxis assay, with IC50 < 100 nM. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
In vivo, CCX354 has in vivo anti-inflammatory activity and has superior pharmacokinetic properties. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Compounds for the treatment of osteoporosis and cancers. US 20100113472 A1